Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.
Transformational medtech innovation needs more than a great idea. It needs the right engineering, clinical evidence, reimbursement strategy, and commercialization support to reach patients.
In this episode, Peter Lewis, Executive Vice President of Business Development at Hydrix, joins Saul Marquez at the MedTech Innovator Radar Forum to discuss what it takes to bring complex, safety-critical medical devices to market. Peter shares Hydrix’s evolution from its origins in Australia to becoming a global medical product development company supporting cardiac, surgical robotics, imaging, neurostimulation, and other advanced technologies. He highlights why clinician-led innovation is especially powerful, what distinguishes today’s most promising medtech startups, and why AI, reimbursement, and human clinical evidence are now essential pillars for growth.
Tune in to learn what medtech innovators need to consider early if they want to build solutions that truly change care.
Resources:
Connect with and follow Peter Lewis on LinkedIn or reach out via email.
